Discovery platform leveraging novel microproteins that confer resistance to trichothecene mycotoxins produced by Fusarium graminearum. A yeast-derived microprotein provides full resistance to lethal doses, with plans to identify plant analogs that could enable durable fungal resistance in crops.
Fusarium graminearum is a devastating fungal pathogen that produces trichothecenes, potent mycotoxins that contaminate grain crops and threaten food security. This research explores a novel defense mechanism based on microproteins—small proteins encoded by short open reading frames that are often overlooked in traditional genomic analyses. The team has identified a microprotein from yeast that confers full resistance to more than double the lethal dose of the type B trichothecene trichothecin, without altering cell membrane permeability. The central hypothesis is that plants produce analogous microproteins that participate in the fungal-plant interaction, opening a new avenue for engineering durable resistance to Fusarium and reducing mycotoxin contamination in cereals.
The technology is at an early discovery stage (TRL 2–3). A lead microprotein has been validated in yeast with demonstrated resistance to trichothecin, and specificity controls have been performed. The next phase involves Biacore-based ligand fishing, mass spectrometry identification of binding partners, and functional characterization of microprotein-protein interactions. Extension of the platform to identify plant microproteins with roles in fungal resistance represents the longer-term translational pathway toward agricultural applications.
Rutgers University is a comprehensive public research university and New Jersey’s flagship, spanning campuses in New Brunswick–Piscataway, Newark, and Camden. For industry, it offers an integrated clinical and biomedical enterprise through its health system, a statewide extension network for field deployment, and campus-based incubators and pilot-scale facilities that enable prototyping and scale-up. Companies engage through sponsored research, shared core facilities, professional education, and flexible partnership models supported by corporate engagement teams. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and USDA. A dedicated technology transfer office manages IP, licensing, material transfer, and startup formation, providing clear pathways from lab discovery to market.